BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 486540)

  • 1. Inhibition of factor VIII-associated platelet aggregation by heparin and dextran sulfate, and its mechanism.
    Suzuki K; Nishioka J; Hashimoto S
    Biochim Biophys Acta; 1979 Jul; 585(3):416-26. PubMed ID: 486540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of heparin on the interaction of factor VIII and human platelets in vitro.
    de Marco L; Fabris F; Molaro G; Girolami A
    Haemostasis; 1977; 6(3):163-70. PubMed ID: 885379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran 40 reduces heparin-mediated platelet aggregation.
    Sobel M; Adelman B; Greenfield LJ
    J Surg Res; 1986 Apr; 40(4):382-7. PubMed ID: 2422443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borate and glycerol inhibition of the aggregation of guinea pig platelets by bovine factor VIII and ristocetin.
    Kuwahara SS
    Am J Hematol; 1977; 2(2):159-72. PubMed ID: 888824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of bovine factor VIII with human platelets.
    Kirby EP; Mills DC
    J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dextran on factor VIII (antihemophilic factor) and platelet function.
    Aberg M; Hedner U; Bergentz SE
    Ann Surg; 1979 Feb; 189(2):243-7. PubMed ID: 426556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural studies on the surface coat of human platelet aggregated by polylysine and dextran.
    Taketomi Y; Kuramoto A
    Thromb Haemost; 1978 Aug; 40(1):11-23. PubMed ID: 725840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The agglutination of human platelets by bovine factor VIII: R.
    Kirby EP
    J Lab Clin Med; 1982 Dec; 100(6):963-76. PubMed ID: 6183384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
    Reches A; Eldor A; Salomon Y
    Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation.
    Eldor A; Weksler BB
    Thromb Res; 1979; 16(5-6):617-28. PubMed ID: 392805
    [No Abstract]   [Full Text] [Related]  

  • 12. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G; Nagai T; Nagasawa K
    Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human platelet aggregation by the proteolytic effect of streptokinase. Role of the human factor-VIII-related protein.
    Castillo R; Maragall S; Guisasola JA; Casals F; Profitós J; Ordinas A
    Haemostasis; 1976; 5(5):306-17. PubMed ID: 1087912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Inhibition of bovine factor VIII and ristocetin plus human factor VIII induced platelet agglutination by small peptides.
    Macfarlane DE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582-3. PubMed ID: 1239092
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.
    De Marco L; Shapiro SS
    J Clin Invest; 1981 Aug; 68(2):321-8. PubMed ID: 6790574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
    Vermylen J; Bottecchia D; Szpilman H
    Br J Haematol; 1976 Oct; 34(2):321-30. PubMed ID: 974043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among bovine and human factor VIII, ristocetin, and DL-polylysine in the induction of guinea pig platelet aggregation.
    Kuwahara SS; Malik M
    Physiol Chem Phys; 1979; 11(4):337-44. PubMed ID: 538097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.